Wed, May 8, 2024
Tue, May 7, 2024
Mon, May 6, 2024

Brian Abrahams Maintained (VRTX) at Hold with Increased Target to $424 on, May 7th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-424-on-may-7th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Increased Target from $417 to $424 on, May 7th, 2024.

Brian has made no other calls on VRTX in the last 4 months.



There are 14 other peers that have a rating on VRTX. Out of the 14 peers that are also analyzing VRTX, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • William Pickering of "Bernstein" Downgraded from Buy to Hold on, Friday, February 2nd, 2024
  • Naz Rahman of "Maxim Group" Downgraded from Strong Buy to Hold on, Wednesday, January 31st, 2024


These are the ratings of the 12 analyists that currently disagree with Brian


  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $450 on, Thursday, April 18th, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
  • Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $440 on, Tuesday, February 20th, 2024
  • Andy Chen of "Wolfe Research" Initiated at Buy on, Thursday, February 15th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $472 on, Tuesday, February 6th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $540 on, Tuesday, February 6th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $450 on, Tuesday, February 6th, 2024
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $508 on, Wednesday, January 31st, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $559 on, Wednesday, January 31st, 2024

Publication Contributing Sources